CME Group (CME) Q3 2025 Earnings
How Did CME Stock React to Q3 2025 Earnings?
S&P 500 over the same 30 days: −1.31%.
Did CME Beat Earnings? Q3 2025 Results
Yes. CME Group reported Q3 2025 earnings of $2.68 a share on Oct 22, 2025, beating the $2.63 consensus estimate by 2.0%. Revenue was $1.5B against a $1.5B estimate.
CME Group posted a modest earnings beat in the third quarter of 2025, with adjusted diluted EPS of $2.68 topping the $2.64 consensus estimate by 1.52%, even as total revenue slipped 3.0% year-over-year to $1.54 billion. The primary drag was a decline in clearing and transaction fees, which fell to $1.23 billion from $1.30 billion a year earlier, reflecting a drop in average daily volume to 25,322 thousand contracts from 28,289 thousand in Q3 2024, with interest rate and equity index products leading the pullback. A higher average rate per contract, rising to $0.70 from $0.67, helped cushion the blow, as did record market data revenue of $202.50 million. Looking ahead, CME is leaning into new growth vectors to rebuild momentum; a partnership with FanDuel and the launch of 24/7 cryptocurrency futures and options trading are central to that push, and early signs are encouraging, with October already delivering record average daily volumes driven by a surge in metals and cryptocurrency contracts.
- Second-highest third-quarter ADV driven by global client demand across all asset classes
- Record market data revenue of $203 million
- Average rate per contract increased to $0.702 from $0.666 year-over-year
- Ongoing global uncertainty driving risk management activity
“Global clients continued relying on CME Group markets across all asset classes as they sought to navigate risk and pursue opportunities amid ongoing uncertainty in Q3.”
CME Group CEO, on the earnings call
What Was CME Group's Outlook in Q3 2025?
CME Group is focused on delivering efficiencies, new products, and expanded access for market participants. Key forward-looking initiatives include a new partnership with FanDuel and the launch of 24/7 trading in cryptocurrency futures and options to broaden market access and drive growth.
CME YoY Financials
| Metric | Q3 2025 | Q3 2024 | Year over year |
|---|---|---|---|
| Revenue | $1.5B | $1.6B | −2.9% |
| Operating Income | $972.6M | $1.0B | −5.0% |
| Net Income | $908.0M | $912.8M | −0.5% |
CME Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.